TCI Wealth Advisors’s Aevi Genomic Medicine Inc GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,000
| Closed | – | – | 1882 |
|
|
2019
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1752 |
|
|
2019
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1709 |
|
|
2019
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1629 |
|
|
2019
Q1 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1615 |
|
|
2018
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1394 |
|
|
2018
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1422 |
|
|
2018
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1460 |
|
|
2018
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1332 |
|
|
2017
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1270 |
|
|
2017
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1287 |
|
|
2017
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1007 |
|
|
2016
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 795 |
|
|
2016
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 711 |
|
|
2016
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 697 |
|
|
2016
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 806 |
|
|
2015
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 696 |
|
|
2015
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 563 |
|
|
2015
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 626 |
|
|
2015
Q1 | $8K | Hold |
1,000
| – | – | 0.01% | 504 |
|
|
2014
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 581 |
|
|
2014
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 583 |
|
|
2014
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 510 |
|
|
2014
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 504 |
|
|
2013
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 530 |
|
|
2013
Q3 | $8K | Hold |
1,000
| – | – | 0.01% | 418 |
|
|
2013
Q2 | $4K | Buy |
+1,000
| New | +$4.1K | ﹤0.01% | 509 |
|
TCI Wealth Advisors's GNMX Position: Q1 2020 in Review
TCI Wealth Advisors sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 1,000 shares.
TCI Wealth Advisors first reported a position in GNMX in Q2 2013 and held it in 27 quarters. The position peaked at $8K in Q3 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.
- TCI Wealth Advisors reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
- TCI Wealth Advisors sold 1,000 Aevi Genomic Medicine Inc shares in Q1 2020.
- TCI Wealth Advisors first reported a position in Aevi Genomic Medicine Inc in Q2 2013 and held it in 27 quarters.
- TCI Wealth Advisors's Aevi Genomic Medicine Inc position peaked at $8K in Q3 2015.
- 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.
Based on TCI Wealth Advisors's 13F filing for Q1 2020, filed 14 Apr 2020.